2025-07-31-accounts - Association For The Global Advancement Of Ent Surgery And Head And Neck Cancer Research

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

	Association for the Global Advancement of ENT Surgery and Head and Neck Cancer Research	Association for the Global Advancement of ENT Surgery and Head and Neck Cancer Research	Association for the Global Advancement of ENT Surgery and Head and Neck Cancer Research	1165453	CC16a
	For the period from	01/08/2024	To	31/07/2025

Section A Receipts and payments
A1 Receipts	Unrestricted funds to the nearest £ 49,845 - - 11 - - - - 49,856 - - - 49,856 121 39 10,259 - 87 232 870 185 - 11,793 - - - 11,793 38,063 - 15,660 53,723	Restricted funds to the nearest £ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -	Endowment funds to the nearest £ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -	Total funds to the nearest £ 49,845 - - 11 - - - - 49,856 - - - 49,856 121 39 10,259 - 87 232 870 185 - 11,793 - - - 11,793 38,063	Last year to the nearest £
Donations	49,845				104,585
	-
	-				-
Bank interest	11				9
	-				-
	-				-
	-				-
	-				-
*Sub total*(Gross income for AR)	49,856				104,594

A2 Asset and investment sales, (see table).
	-
	-				-
*Sub total*	-				-
*Total receipts* A3 Payments
					104,594

Fundraisingcosts	121				61
Web hostingand website costs	39				899
Fellowships and Grants	10,259				91,296
FundingApplication	-				-
Office costs	87				113
Travel expenses re: researchgrant	232				-
Legal andprofessional fees	870				690
Sundryexpenses	185				-
	-				-
**Sub total **	11,793				93,059

A4 Asset and investment purchases, (see table)
	-
	-
**Sub total **	-				-
*Total payments* *Net of receipts/(payments)* A5 Transfers between funds A6 Cash funds last year end *Cash funds this year end*
					93,059

	38,063	-	-	38,063	11,536
	-	-	-	-	-
	15,660	-	-	15,660	4,124
	53,723	-	-	53,723	15,660

Section B Statement of assets and liabilities at the end of the	Section B Statement of assets and liabilities at the end of the	Section B Statement of assets and liabilities at the end of the
Categories Signed by one or two trustees on behalf of all the trustees B5 Liabilities B4 Assets retained for the charity’s own use B3 Investment assets B2 Other monetary assets B1 Cash funds	Signature Details Details *Total cash funds* (agree balances with receipts and payments account(s)) Details Details Details Bank accounts	Unrestricted funds Restricted funds to nearest £ to nearest £ 53,723 - - - - - 53,723 - OK OK Unrestricted funds Restricted funds to nearest £ to nearest £ - - - - - - - - - - - - Fund to which asset belongs Cost (optional) - - - - - Fund to which asset belongs Cost (optional) - - - - - - - - - Fund to which liability relates Amount due (optional) - - - - Print Name M Lechner	Endowment funds to nearest £
			-
			-
			-
			-
			OK
			Endowment funds to nearest £
			-
			-
			-
			-
			-
			-
			Current value (optional)
			-
			-
			-
			-
			-
			Current value (optional)
			-
			-
			-
			-
			-
			-
			-
			-
			-
			When due (optional)






			Date of approval
			29/5/2026

Trustees’ Annual Report for the period

From 31/7/2024 Period start date To 31/7/2025 Period end date

Charity name: ASSOCIATION FOR THE GLOBAL ADVANCEMENT OF ENT SURGERY AND HEAD AND NECK CANCER RESEARCH

Charity registration number: 1165453

Objectives and Activities

	SORP reference
Summary of the purposes of the charity as set out in its governing document	Para 1.17	The advancement of health and relief of sickness in the field of ear, nose and throat/head and neck surgery and head and neck disorders across the world in particular but not exclusively by: · Supporting the provision of awareness and screening programmes · Supporting cancer research by the provision of grants (AGA-ENT Charity Governing document - version 1.1-21/1/2016)
Summary of the main activities in relation to those purposes for the public benefit, in particular, the activities, projects or services identified in the accounts.	Para 1.17 and 1.19	· Supporting the provision of awareness and screening programmes · Supporting cancer research by the provision of grants and support for UK and international research
Statement confirming whether the trustees have had regard to the guidance issued by the Charity Commission on public benefit	Para 1.18	Yes, the trustees have had regard.

Additional information (optional) You may choose to include further statements where relevant about:

SORP reference N/A Para 1.38 Policy on grant making N/A Para 1.38 Policy on social investment including program related investment

Contribution made by volunteers	Para 1.38	Minor contributions, e.g. help with social media.
Other		N/A

Achievements and Performance

	SORP reference
Summary of the main achievements of the charity, identifying the difference the charity’s work has made to the circumstances of its beneficiaries and any wider benefits to society as a whole.	Para 1.20	Our main focus remained to drive forward research into betel nut-induced oral cancer and nasopharyngeal cancer, supported by grants and donations. Furthermore, we have supported fellows with grants. In detail, we have awarded £4k of fellowship funds for 2025 with fellows travelling to Malawi and India. We have continued to closely work with our partners around the world and the company KARL STORZ has continued to support our programme.

Additional information (optional) You may choose to include further statements where relevant about:

Achievements against objectives set	Para 1.41	As above. Taking the above work into account AGA-ENT has made contributions to the advancement of health and relief of sickness in the field of ear, nose and throat/head and neck surgery and head and neck disorders in low and middle income countries.
Performance of fundraising activities against objectives set	Para 1.41	Good progress.
Investment performance against objectives	Para 1.41	N/A
Other		N/A

Financial Review

Review of the charity’s financial position at the end of the period	Para 1.21	31/7/2024
Statement explaining the policy for holding reserves stating why they are held	Para 1.22	Year on year the charity hopes to increase the reserves to be in line with 2 years possible commitments
Amount of reserves held	Para 1.22	£1000
Reasons for holding zero reserves	Para 1.22	N/A
Details of fund materially in deficit	Para 1.24	N/A
Explanation of any uncertainties about the charity continuing as a going concern	Para 1.23	N/A

Details of fund materially in deficit Para 1.24 Explanation of any uncertainties about the charity continuing as a going concern Para 1.23	Details of fund materially in deficit Para 1.24 Explanation of any uncertainties about the charity continuing as a going concern Para 1.23	N/A N/A
Additional information (optional) You may choose to include further statements		where relevant about:
The charity’s principal sources of funds (including any fundraising)	Para 1.47	Donations by private donors and donated equipment.
Investment policy and objectives including any social investment policy adopted	Para 1.46	N/A
A description of the principal risks facing the charity	Para 1.46	At present funds are sufficient to achieve the aims set, but more funding needs to be sought to continue to expand our work. Ensuring the ongoing income is the most important risk we manage.
Other		N/A

Structure, Governance and Management

Description of charity’s trusts:
Type of governing document (trust deed, royal charter)	Para 1.25	Constitution of the Association for the Global Advancement of ENT Surgery and Head and Neck Cancer Research (AGA- ENT), a Charitable Incorporated Organisation with voting members other than its charity trustees Date of constitution (last amended): 21/01/2016 (AGA-ENT Charity Governing document - version 1.1 - 21/1/2016)
How is the charity constituted? (e.g unincorporated association, CIO)	Para 1.25	Charitable Incorporated Organisation
Trustee selection methods including details of any constitutional provisions e.g. election to post or name of any person or body entitled to appoint one or more trustees	Para 1.25	The current trustees volunteered to take on these roles with the support of all founding members and fulfil these roles in line with the duties outlined in the AGA-ENT Charity Governing document - version 1.1 - 21/1/2016

Additional information (optional) You may choose to include further statements where relevant about:

Policies and procedures adopted for the induction and training of trustees	Para 1.51	All duties outlined in the AGA-ENT Charity Governing document - version 1.1 - 21/1/2016 and discussed during regular Trustees’ meetings.
The charity’s organisational structure and any wider network with which the charity works	Para 1.51	Charitable Incorporated Organisation with voting members other than its charity trustees
Relationship with any related parties	Para 1.51	Collaborators and partners globally who help to achieve the outlined objectives, usually within the network of Founding Members.
Other		N/A

Reference and Administrative details

Charity name	Association for the Global Advancement of ENT Surgery and Head and Neck Cancer Research (AGA-ENT)
Other name the charity uses	AGA-ENT
Registered charity number	1165453

Charity’s principal address	Association for the Global Advancement of ENT Surgery and Head and Neck Cancer Research (AGA-ENT), c/o Kershen Fairfax Limited, 4th Floor, Eldon Chambers, 30-32 Fleet Street, London, England, EC4Y 1AA

Names of the charity trustees who manage the charity

Trustee name	Dates acted if not for whole year	Name of person (or body) entitled to appoint trustee(if any)
Paul O’Flynn	5/2/2016 – current date	Membershipbody
Matt Lechner	5/2/2016 – current date	Membershipbody
Valerie J. Lund	5/2/2016 – current date	Membershipbody
Francis M. Vaz	5/2/2016 – current date	Membershipbody
Tim Tang	5/2/2016 - 4/6/2017	Membershipbody
TerryM. Jones	6/6/2023 – current date	Membershipbody

– Corporate trustees names of the directors at the date the report was approved

Director name N/A

Name of trustees holding title to property belonging to the charity

Trustee name	Dates acted if not for whole year
N/A

Funds held as custodian trustees on behalf of others

Description of the assets None held in this capacity Name and objects of the N/A charity on whose behalf the assets are held and how this falls within the custodian charity’s objects Details of arrangements for N/A safe custody and segregation of such assets from the charity’s own assets

Additional information (optional)

Names and addresses of advisers (Optional information)

Additional information (optional) Names and addresses of advisers (Optional information)	Additional information (optional) Names and addresses of advisers (Optional information)	Additional information (optional) Names and addresses of advisers (Optional information)
Type of adviser Name Address
N/A



Name of chief executive or names of senior staff members (Optional information)
N/A

N/A

Exemptions from disclosure

Reason for non-disclosure of key personnel details

The charity is still too small still to employ personnel.

Other optional information

N/A

Declarations

The trustees declare that they have approved the trustees’ report above.

Signed on behalf of the charity’s trustees

Signature(s) Full name(s) Prof. Matt Lechner Position (eg Secretary, Trustee Chair, etc) Date 26/05/2026